https://www.selleckchem.com/pr....oducts/l-mimosine.ht
ring resistance levels leading to treatment failure in genotype 4. The high barrier to resistance of glecaprevir/pibrentasvir could prevent persistence and propagation of antiviral resistance. History of cardiovascular diseases (CVDs) may influence the prognosis of patients hospitalised for COVID-19. We investigated whether patients with previous CVD have increased risk of death and major adverse cardiovascular event (MACE) when hospitalised for COVID-19. We included 839 patients with COVID-19 hospitalised at the University Hospitals
Like
Comment
Share
